1. Home
  2. GRPN vs VNDA Comparison

GRPN vs VNDA Comparison

Compare GRPN & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$12.08

Market Cap

576.7M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.93

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
VNDA
Founded
2008
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.7M
474.0M
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
GRPN
VNDA
Price
$12.08
$6.93
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$33.67
$14.90
AVG Volume (30 Days)
1.6M
1.6M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,843,877,000.00
$216,105,000.00
Revenue This Year
$5.55
$21.35
Revenue Next Year
$6.63
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$9.17
$3.81
52 Week High
$41.26
$9.91

Technical Indicators

Market Signals
Indicator
GRPN
VNDA
Relative Strength Index (RSI) 53.68 41.77
Support Level $11.86 $4.39
Resistance Level $13.80 $8.29
Average True Range (ATR) 0.80 0.44
MACD 0.23 -0.12
Stochastic Oscillator 91.00 14.37

Price Performance

Historical Comparison
GRPN
VNDA

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: